4.7 Article

CircHIPK3 prevents chondrocyte apoptosis and cartilage degradation by sponging miR-30a-3p and promoting PON2

期刊

CELL PROLIFERATION
卷 55, 期 9, 页码 -

出版社

WILEY
DOI: 10.1111/cpr.13285

关键词

-

资金

  1. China Postdoctoral Science Foundation [2019M663268]
  2. Guangdong Medical Research Foundation [A2020283]
  3. National Natural Science Foundation of China [81572174, 81772384, 81902242]
  4. Science and Technology Project of Jiangxi Provincial Education Department [GJJ210176]
  5. Medical Science and Technology Planning Project of Zhuhai [ZH2201200003HJL]

向作者/读者索取更多资源

circHIPK3 regulates chondrocyte apoptosis through the mitochondrial pathway, and its interaction with miR-30a-3p and PON2 may serve as potential targets for osteoarthritis treatment.
Osteoarthritis (OA) is a common joint disease featured by the deterioration of articular cartilage and chondrocyte death. Emerging evidence has indicated that circular RNAs (circRNAs) play an essential role in OA progress. Here, we found that the expression of circHIPK3 was significantly decreased in human and mouse OA cartilage. Knocking down circHIPK3 increased apoptosis and intracellular ROS level in HC-a chondrocytes. We performed proteomic studies and identified that circHIPK3 regulated chondrocyte apoptosis through the mitochondrial pathway. Results of JC-1 staining and western blot further confirmed that mitochondrial outer membrane permeabilization was promoted in HC-a chondrocytes transfected by circHIPK3 siRNA. In terms of mechanism, we showed that PON2 functioned as a potential target of circHIPK3 to regulate chondrocyte apoptosis. Moreover, we revealed that circHIPK3 interacted with miR-30a-3p to regulate PON2 expression in chondrocytes. Taken together, our findings suggested that circHIPK3 regulated chondrocyte apoptosis by mitochondrial pathway, and targeting the circHIPK3/miR-30a-3p/PON2 axis might be a potential strategy for OA treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据